Transfusion-related immunosuppression

Anaesthesia and Intensive Care Medicine

Volumn 10, Issue 5, 2009, Pages 231-234

  Hellings, Simon ^a,b   Blajchman, Morris A ^a,b  

^a North West Anaesthetics rotation ^*

^b CANADIAN BLOOD SERVICES   (Canada)

Author keywords

allogeneic; blood; immunosuppression; transfusion; transfusion related immunomodulation; TRIM; white blood cells

Indexed keywords

HLA ANTIGEN;

BACTERIAL INFECTION; BLOOD TRANSFUSION REACTION; CANCER RECURRENCE; CLINICAL TRIAL; ERYTHROCYTE TRANSFUSION; GRAFT SURVIVAL; HEART SURGERY; HUMAN; IMMUNE DEFICIENCY; IMMUNOMODULATION; INFECTION RISK; KIDNEY TRANSPLANTATION; LEUKOCYTE TRANSFUSION; MACROPHAGE; MICROCHIMERISM; MORTALITY; NATURAL KILLER CELL; NONHUMAN; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW;

EID: 65549103701     PISSN: 14720299     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpaic.2009.01.017     Document Type: Review

References (10)

1. Hébert P.C., Wells G., Blajchman M.A., et al. A multicentre, randomised, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 340 (1999) 409-417
2. Opelz G., Sengar D.P., Mickey M.R., et al. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 5 (1973) 253-259
3. Adamson J.W. New blood, old blood or no blood?. N Engl J Med 12 (2008) 1295
4. Van de Watering L.M.G., Hermans J., Hobiers J.G.A., et al. Beneficial effect of leucocyte depletion of transfused blood on post-operative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 97 (1998) 562-568
5. Gantt C.L. Red blood cells for cancer patients. Lancet 2 (1981) 363
6. Vamvakas E.C., and Blajchman M.A. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 21 (2007) 327-348
7. Vamvakas E.C. Transfusion-associated cancer recurrence and infection: meta-analysis of the randomized controlled clinical trials. Transfusion 36 (1996) 175-186
8. Blajchman M.A. Transfusion immunomodulation or TRIM: what does it mean clinically?. Haematology 10 Suppl. 1 (2005) 208-214
9. Blajchman M.A. Transfusion-associated immunomodulation and universal white cell reduction: are we putting the cart before the horse?. Transfusion 39 (1999) 665-670
10. Vamvakas E.C. White-blood-cell containing allogenic blood transfusion, postoperative infection, and mortality: a meta-analysis of observational, 'before-and-after' studies. Vox Sang 86 (2004) 111-119